Tracking gluten immunoreactive peptides from the grain to the gut and beyond

GLUTENOMICS aims to identify and analyze gluten immunoreactive peptides in human biosamples to improve grain-based food tolerability and prevent wheat-related disorders.

Subsidie
€ 1.499.988
2022

Projectdetails

Introduction

Wheat is one of the pillars for nutrition security worldwide, but the prevalence of wheat-related disorders (WRD) is increasing. Taken together, coeliac disease, non-coeliac gluten sensitivity, and wheat food allergy may affect up to 10% of European individuals. The causes for this increase are still unknown, but involve the intricate interaction of proteolytically resistant gluten immunoreactive peptides (GIP) from wheat, rye, and barley, the human immune system, and yet unknown adjuvants.

Current Challenges

Total GIP can be detected by immunoassays in human plasma, urine, and faeces (biosamples) after gluten consumption. However, the precise molecular structures have not been clarified so far because specific analytical methods are missing.

Project Objectives

The project GLUTENOMICS aims to elucidate the molecular structures of GIP in human biosamples and analyze factors determining their identities and quantities. The objectives include:

  1. Creating a comprehensive database of GIP and elucidating factors affecting gluten protein digestibility.
  2. Developing and validating proteomics methods to detect GIP in human biosamples.
  3. Establishing relations between the GIP profile of raw materials, foods, and human biosamples.

Central Hypothesis

My central hypothesis is that gluten structure and content determine its digestibility, which, in turn, leads to different GIP profiles in biosamples from healthy individuals and WRD patients.

Methodology and Impact

The unique toolbox of methods that I will put in place will provide a fundamentally new understanding of how protein structures govern digestibility and how the resulting peptides pass through the human digestive system.

Future Aspirations

My ambition is to use the findings to tailor grain-based foods towards better tolerability to prevent the initial onset of WRD. Beyond grains, GLUTENOMICS opens significant innovative potential to promote human health through systematically structured, isolated, or designed dietary proteins.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.988
Totale projectbegroting€ 1.499.988

Tijdlijn

Startdatum1-9-2022
Einddatum31-8-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • KARLSRUHER INSTITUT FUER TECHNOLOGIEpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Consolid...

Nanostructure formation during food protein digestion and influence on intestinal transport

PRODIGEST aims to enhance sustainable food production by investigating the structural and mechanistic aspects of protein digestion to improve nutrient bioavailability and health outcomes.

€ 2.355.741
ERC Consolid...

3Dwheat, A 3 Dimensional functional genomics approach to identify hidden targets controlling heat stress and priming in wheat

This project aims to enhance heat stress resistance in wheat by developing a tri-dimensional functional genomics approach to understand epigenetic mechanisms and create innovative breeding tools.

€ 1.999.995
ERC Starting...

Defusing mini-chromosomes—the Achilles’ heel of the wheat blast pandemic

The PANDEMIC project aims to develop non-transgenic wheat disease resistance by targeting a unique mini-chromosome in the virulent wheat blast fungus using gene editing and biophysical analysis.

€ 1.499.999
ERC Starting...

Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species

This project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health.

€ 1.499.980
ERC Consolid...

Exploring functional inter-individual variations in the intestinal microbiome for personalized nutrition

The InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies.

€ 2.000.000

Vergelijkbare projecten uit andere regelingen

EIC Accelerator

First ever preventive treatment for celiac disease and gluten sensitivity

E40 is a novel gluten-degrading enzyme designed to improve quality of life for Celiac and gluten-sensitive individuals by reducing gluten's inflammatory effects during digestion.

€ 2.499.999
EIC Pathfinder

Precision Nutrition to optimize immune response for metabolic health

NUTRIMMUNE investigates the impact of precision nutrition on immune responses in obesity-related NCDs, aiming to establish dietary recommendations through multi-omics analysis and intervention studies.

€ 4.318.432
EIC Pathfinder

Glucose variability patterns for precision nutrition in diabetes

The GLUCOTYPES project aims to identify early glycaemic patterns and their dietary influences using advanced technologies to develop precision nutrition strategies for Type 2 diabetes prevention and management.

€ 3.988.206
EIC Accelerator

Novel First-in-Class Specific Oromucosal Immunotherapy (SOMIT) to treat Celiac Disease (CD)

The project aims to develop a novel treatment for celiac disease using a combination of gliadin protein, probiotic particles, and mouth patch technology, targeting market entry by 2029.

€ 2.499.993
EIC Pathfinder

Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout Prevention

This project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses.

€ 3.765.840